Promising Phase 2 Results for Efgartigimod alfa-fcab in Adults with Primary Sjögren’s Disease Michele B. Kaufman, PharmD, BCGP | Issue: September 2025 | August 26, 2025 Page: 1 2 3 | Single Page Share: